“Alexander: NIH and FDA Must Keep Pace with Today’s Cutting-edge Scientific Advances”
“We found that medical products take more time and money to discover, develop, and reach American patients than ever before.
We also found that FDA has struggled to regulate the most cutting-edge medical products. The disparity between the pace of scientific discovery and FDA’s scientific knowledge is threatening America’s position as a global leader in medical innovation.
We reported that the venture capital community is shifting investments away from early-stage drugs and devices as a result of increasing regulatory burden and uncertainty…
These are big challenges that are slowing down the process for getting the cutting edge innovations we are discovering into the medicine cabinet and the doctor’s office.”